References
- Gilfillan L, Smith BT, Inglesby TV, Kodukula K, Schuler A, Lister M, et al. Taking the measure of countermeasures: leaders’ views on the nation’s capacity to develop biodefense countermeasures. Biosecur Bioterror 2004; 2:320 - 7; http://dx.doi.org/10.1089/bsp.2004.2.320; PMID: 15650441
- Patrick WC. Interviews with Biowarriors. Interview by Broad B, Wolfinger K. NOVA. PBS. 2001 Nov 01. Accessed at: http://www.pbs.org/wgbh/nova/bioterror/biow_patrick.html.
- Wolfe DN, Florence W, Bryant P. Current biodefense vaccine programs and challenges. Hum Vaccin Immunother 2013; 9; In press http://dx.doi.org/10.4161/hv.24063; PMID: 23428906
- De Groot AS, Einck L, Moise L, Chambers M, Ballantyne J, Malone RW, et al. Inc. Ardito M, Martin W. FastVax: Biodefense Vaccine Production “On Demand”. Hum Vaccin Immunother 2013; 9 In press
- Thomas SJ. Dengue human infection model: Re-establishing a tool for understanding dengue immunology and advancing vaccine development. Hum Vaccin Immunother 2013; 9; In press http://dx.doi.org/10.4161/hv.24188; PMID: 23466948
- Raj DK, Nixon CP, Fried M, Duffy PE, Kurtis JD. Vaccine candidate identification for pediatric falciparum malaria. Poster presentation. American Society of Tropical Medicine and Hygiene 60th Annual Meeting. Philadelphia, PA. 2011 Dec 4-8. Am J Trop Med Hyg 2011; 85:Suppl 6 222
- Self AA, Losikoff PT, Gregory SH. Regulatory T cells promote the pathogenesis of chronic hepatitis C infection. Hum Vaccin Immunother 2013; 9; In press PMID: 23732899
- Trobaugh DW, Yang L, Ennis FA, Green S. Altered effector functions of virus-specific and virus cross-reactive CD8+ T cells in mice immunized with related flaviviruses. Eur J Immunol 2010; 40:1315 - 27; http://dx.doi.org/10.1002/eji.200839108; PMID: 20213733
- Steele J, Sponseller J, Schmidt D, Cohen O, Tzipori S. Hyperimmune bovine colostrum for treatment of GI infections: A review and update on Clostridium difficile. Hum Vaccin Immunother 2013; 9; In press http://dx.doi.org/10.4161/hv.24078; PMID: 23435084
- Bhattacharya D, Bensaci M, Luker KE, Luker G, Wisdom S, Telford SR, et al. Development of a baited oral vaccine for use in reservoir-targeted strategies against Lyme disease. Vaccine 2011; 29:7818 - 25; http://dx.doi.org/10.1016/j.vaccine.2011.07.100; PMID: 21816190
- Sam TAR. Hum Vaccin Immunother 2013; 9 In press
- Kaba SA, Brando C, Guo Q, Mittelholzer C, Raman S, Tropel D, et al. A nonadjuvanted polypeptide nanoparticle vaccine confers long-lasting protection against rodent malaria. J Immunol 2009; 183:7268 - 77; http://dx.doi.org/10.4049/jimmunol.0901957; PMID: 19915055
- Kaba SA, McCoy ME, Doll TA, Brando C, Guo Q, Dasgupta D, et al. Protective antibody and CD8+ T-cell responses to the Plasmodium falciparum circumsporozoite protein induced by a nanoparticle vaccine. PLoS One 2012; 7:e48304; http://dx.doi.org/10.1371/journal.pone.0048304; PMID: 23144750
- Wang JY, Harley RH, Galen JE. Novel methods for expression of foreign antigens in live vector vaccines. Hum Vaccin Immunother 2013; 9; In press http://dx.doi.org/10.4161/hv.23248; PMID: 23406777